BCR anticorps (AA 1042-1243)
-
- Antigène Voir toutes BCR Anticorps
- BCR (Breakpoint Cluster Region (BCR))
-
Épitope
- AA 1042-1243
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp BCR est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC)
- Specificité
- The antibody is a rabbit polyclonal antibody raised against BCR. It has been selected for its ability to recognize BCR in immunohistochemical staining and western blotting.
- Purification
- Antigen-specific affinity chromatography
- Immunogène
- BCR (Arg1042-Val1243)
- Isotype
- IgG
- Top Product
- Discover our top product BCR Anticorps primaire
-
-
- Indications d'application
-
- Western blotting: 1:50-400 Immunocytochemistry in formalin fixed cells: 1:50-500 Immunohistochemistry in formalin fixed frozen section: 1:50-500 Immunohistochemistry in paraffin section: 1:10-100 Enzyme-linked Immunosorbent Assay: 1:100-1:5000 Optimal working dilutions must be determined by end user.
- Commentaires
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
-
- Antigène
- BCR (Breakpoint Cluster Region (BCR))
- Abstract
- BCR Produits
- Synonymes
- anticorps si:dkey-83d9.7, anticorps zK83D9.7, anticorps BCR, anticorps ALL, anticorps BCR1, anticorps CML, anticorps D22S11, anticorps D22S662, anticorps PHL, anticorps 5133400C09Rik, anticorps AI561783, anticorps AI853148, anticorps mKIAA3017, anticorps breakpoint cluster region, anticorps BCR, RhoGEF and GTPase activating protein, anticorps bcr, anticorps BCR, anticorps Bcr
- Sujet
- Alternative Names: ALL, BCR/FGFR1, BCR1, CML, FGFR1/BCR, PHL, Renal carcinoma antigen NY-REN-26
- Pathways
- Regulation of Leukocyte Mediated Immunity, Platelet-derived growth Factor Receptor Signaling
-